Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.06 trillion and total revenue of $110.13 billion.
Market Cap
1.06T
Revenue
110.13B
Profits
-41.94B
PE Ratio
n/a
Profit Margin
-38.08%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.72B | -2.36% | 1,410,598 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.67B | -1.97% | 671,876 | 14.34B |
| 3 | ARGX | argenx SE | 41.88B | -3.01% | 348,111 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.75B | -1.75% | 1,077,590 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 31.29B | -1.75% | 407,090 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.76B | -0.85% | 2,001,882 | 606.42M |
| 7 | BNTX | BioNTech SE | 22.62B | -5.12% | 1,295,766 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 20.69B | -2.84% | 6,571,591 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.90B | -1.77% | 4,346,798 | 13.31M |
| 10 | RPRX | Royalty Pharma plc | 19.62B | -0.69% | 3,237,543 | 2.38B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.44B | -1.03% | 2,208,067 | - |
| 12 | INCY | Incyte Corporation | 18.36B | -2.10% | 1,576,823 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.90B | -1.93% | 1,088,080 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.96B | -0.29% | 321,056 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.59B | -1.16% | 1,421,971 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.10B | -1.58% | 1,743,751 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.84B | -0.91% | 2,239,699 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.11B | -0.51% | 623,219 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 10.72B | -1.36% | 2,220,610 | 2.32B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.66B | -1.11% | 2,436,135 | 3.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.14B | -0.27% | 314,906 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 9.65B | -2.08% | 1,175,335 | 6.23M |
| 23 | IBRX | ImmunityBio, Inc. | 8.80B | 4.26% | 22,456,835 | 113.29M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.08B | -2.05% | 464,645 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.04B | -4.81% | 408,939 | 7.46M |
| 26 | TECH | Bio-Techne Corporation | 7.95B | -0.49% | 2,175,354 | 1.22B |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.94B | -1.49% | 2,785,302 | 1.09B |
| 28 | PCVX | Vaxcyte, Inc. | 7.81B | -2.16% | 1,046,027 | - |
| 29 | NUVL | Nuvalent, Inc. | 7.66B | -1.56% | 400,483 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 7.66B | 0.10% | 1,983,661 | 88.04M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.51B | -2.27% | 1,729,669 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.33B | -2.15% | 232,996 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.70B | -0.01% | 2,049,090 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.46B | -2.55% | 429,465 | 39.21M |
| 35 | BLTE | Belite Bio, Inc | 6.35B | -0.04% | 177,713 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.20B | -0.14% | 1,981,523 | 46.02M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.86B | -2.08% | 873,692 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.58B | -2.96% | 1,859,599 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.55B | -0.67% | 1,698,982 | 1.73B |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 5.53B | -5.06% | 1,194,329 | 521.31M |
| 41 | CGON | CG Oncology, Inc. | 5.44B | -6.10% | 1,989,579 | 4.04M |
| 42 | XENE | Xenon Pharmaceuticals Inc. | 5.26B | -0.24% | 1,557,322 | 7.50M |
| 43 | CAI | Caris Life Sciences, Inc. | 5.22B | -0.38% | 3,282,163 | 812.03M |
| 44 | CELC | Celcuity Inc. | 5.21B | -1.40% | 574,369 | - |
| 45 | IMVT | Immunovant, Inc. | 4.80B | -5.98% | 1,424,161 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 4.80B | -4.67% | 3,505,713 | 616.29M |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.64B | -4.41% | 653,973 | - |
| 48 | CRSP | CRISPR Therapeutics AG | 4.58B | -4.79% | 1,475,782 | 3.51M |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.57B | -2.26% | 975,941 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.51B | - | 3,526,196 | 634.21M |
| 51 | TERN | Terns Pharmaceuticals, Inc. | 4.30B | 2.82% | 3,155,061 | - |
| 52 | ERAS | Erasca, Inc. | 4.20B | 1.05% | 4,686,006 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.18B | -0.70% | 192,693 | 268.09M |
| 54 | VKTX | Viking Therapeutics, Inc. | 3.88B | -5.57% | 3,511,554 | - |
| 55 | CNTA | Centessa Pharmaceuticals plc | 3.87B | -0.69% | 1,835,638 | 15.00M |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.77B | -4.86% | 1,864,831 | 7.70M |
| 57 | GPCR | Structure Therapeutics Inc. | 3.68B | -7.59% | 1,273,991 | - |
| 58 | CORT | Corcept Therapeutics Incorporated | 3.54B | -0.63% | 1,654,087 | 761.41M |
| 59 | ADMA | ADMA Biologics, Inc. | 3.54B | -7.93% | 5,036,137 | 510.17M |
| 60 | DNTH | Dianthus Therapeutics, Inc. | 3.51B | -0.05% | 720,821 | 2.04M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.46B | -2.78% | 2,562,838 | 1.07B |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.38B | -3.79% | 945,861 | 22.50M |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.38B | -2.03% | 798,147 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.37B | -1.83% | 954,461 | 1.03B |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.18B | -2.66% | 679,261 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.18B | -3.14% | 1,080,603 | - |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.02B | -1.98% | 2,561,615 | - |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 2.93B | -2.80% | 750,997 | 218.71M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 2.90B | -2.22% | 506,947 | 451.36M |
| 70 | TLX | Telix Pharmaceuticals Limited | 2.85B | 1.08% | 403,597 | 803.79M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.83B | -3.04% | 1,080,718 | 70.85M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.79B | -2.23% | 986,399 | 588.99M |
| 73 | RCUS | Arcus Biosciences, Inc. | 2.78B | -1.68% | 822,217 | 247.00M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.76B | -2.11% | 1,984,954 | 376.07M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.73B | -2.54% | 592,968 | - |
| 76 | TNGX | Tango Therapeutics, Inc. | 2.67B | - | 2,541,359 | 62.38M |
| 77 | ALMS | Alumis Inc. | 2.65B | -3.01% | 1,306,625 | 22.12M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.58B | -1.97% | 1,678,718 | 139.74M |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.49B | -2.88% | 1,103,167 | 490.73M |
| 80 | IMNM | Immunome, Inc. | 2.33B | -0.43% | 988,975 | 6.94M |
| 81 | MAZE | Maze Therapeutics, Inc. | 2.33B | -3.81% | 491,482 | 2.50M |
| 82 | APLS | Apellis Pharmaceuticals, Inc. | 2.29B | -4.94% | 5,271,352 | 1.00B |
| 83 | IRON | Disc Medicine, Inc. | 2.26B | -1.41% | 456,701 | - |
| 84 | WVE | Wave Life Sciences Ltd. | 2.24B | -4.49% | 2,953,541 | 42.73M |
| 85 | AAPG | Ascentage Pharma Group International | 2.24B | -1.43% | 2,492 | 54.52M |
| 86 | MANE | Veradermics, Incorporated | 2.20B | -3.37% | 539,001 | - |
| 87 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | 0.09% | 2,620,323 | 158.18M |
| 88 | GLPG | Galapagos NV | 2.12B | -3.25% | 70,519 | 1.31B |
| 89 | NKTR | Nektar Therapeutics | 2.10B | -2.50% | 581,041 | 55.23M |
| 90 | SNDX | Syndax Pharmaceuticals, Inc. | 2.09B | -0.50% | 1,295,816 | 172.35M |
| 91 | ZLAB | Zai Lab Limited | 2.08B | -1.00% | 593,959 | 460.16M |
| 92 | TYRA | Tyra Biosciences, Inc. | 2.05B | 0.34% | 1,330,615 | - |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.04B | -0.82% | 1,549,953 | 276.98M |
| 94 | ORKA | Oruka Therapeutics, Inc. | 2.02B | -1.23% | 985,951 | - |
| 95 | RARE | Ultragenyx Pharmaceutical Inc. | 1.98B | -5.28% | 2,879,711 | 673.00M |
| 96 | MLYS | Mineralys Therapeutics, Inc. | 1.97B | -4.48% | 2,384,123 | - |
| 97 | CLDX | Celldex Therapeutics, Inc. | 1.90B | -3.71% | 733,098 | 1.55M |
| 98 | MESO | Mesoblast Limited | 1.89B | 0.69% | 311,782 | 65.38M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.87B | -2.70% | 955,706 | 283.06M |
| 100 | ANAB | AnaptysBio, Inc. | 1.86B | -3.82% | 1,038,202 | 234.60M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 1.85B | -2.19% | 2,561,525 | 51.95M |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.83B | -5.63% | 843,711 | 184.42M |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 1.80B | 1.90% | 1,756,276 | 2.20B |
| 104 | CAPR | Capricor Therapeutics, Inc. | 1.78B | -0.93% | 951,004 | 11.13M |
| 105 | RLAY | Relay Therapeutics, Inc. | 1.77B | -3.22% | 1,719,263 | 15.36M |
| 106 | DFTX | Definium Therapeutics, Inc. | 1.76B | -2.49% | 1,907,970 | - |
| 107 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -2.92% | 14,500,295 | 74.68M |
| 108 | ZYME | Zymeworks Inc. | 1.73B | -2.45% | 699,810 | 105.97M |
| 109 | SLNO | Soleno Therapeutics, Inc. | 1.69B | -2.44% | 1,355,620 | 190.41M |
| 110 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | -2.70% | 540,672 | 54.03M |
| 111 | VCEL | Vericel Corporation | 1.64B | -0.62% | 997,165 | 276.26M |
| 112 | NVAX | Novavax, Inc. | 1.63B | -5.92% | 3,908,671 | 1.12B |
| 113 | ELVN | Enliven Therapeutics, Inc. | 1.63B | -1.94% | 1,054,772 | - |
| 114 | INVA | Innoviva, Inc. | 1.62B | -0.77% | 659,327 | 411.33M |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.61B | -1.83% | 640,155 | 868.45M |
| 116 | NBTX | Nanobiotix S.A. | 1.58B | 1.78% | 81,081 | 11.93M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -2.00% | 2,698,023 | 67.67M |
| 118 | OCS | Oculis Holding AG | 1.56B | -2.30% | 154,946 | 1.51M |
| 119 | IOVA | Iovance Biotherapeutics, Inc. | 1.55B | -3.08% | 14,467,751 | 263.50M |
| 120 | SION | Sionna Therapeutics, Inc. | 1.55B | -4.02% | 295,981 | - |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.55B | -2.78% | 1,223,428 | 83.98M |
| 122 | IMCR | Immunocore Holdings plc | 1.52B | -2.25% | 310,204 | 400.02M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.51B | -4.45% | 283,513 | 31.89M |
| 124 | NUVB | Nuvation Bio Inc. | 1.49B | -2.73% | 2,779,692 | 62.90M |
| 125 | PHVS | Pharvaris N.V. | 1.43B | -2.79% | 95,964 | - |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.37B | -4.47% | 1,764,471 | - |
| 127 | BHVN | Biohaven Ltd. | 1.37B | -4.62% | 2,428,698 | - |
| 128 | MBX | MBX Biosciences, Inc. | 1.36B | -3.50% | 493,973 | - |
| 129 | ARDX | Ardelyx, Inc. | 1.36B | -4.80% | 2,907,562 | 407.32M |
| 130 | PVLA | Palvella Therapeutics, Inc. | 1.35B | -5.44% | 207,179 | - |
| 131 | ZBIO | Zenas BioPharma, Inc. | 1.32B | -2.13% | 441,681 | 10.00M |
| 132 | VIR | Vir Biotechnology, Inc. | 1.30B | -1.69% | 2,827,704 | 68.56M |
| 133 | IMTX | Immatics N.V. | 1.30B | -1.53% | 275,254 | 56.67M |
| 134 | ATAI | AtaiBeckley Inc. | 1.29B | -2.47% | 5,209,084 | 4.09M |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.27B | -11.91% | 476,839 | - |
| 136 | OLMA | Olema Pharmaceuticals, Inc. | 1.27B | -3.29% | 1,356,062 | - |
| 137 | RAPP | Rapport Therapeutics, Inc. | 1.27B | -4.51% | 317,882 | - |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.26B | -1.68% | 1,304,391 | 123.67M |
| 139 | TSHA | Taysha Gene Therapies, Inc. | 1.22B | -2.63% | 1,756,199 | 6.31M |
| 140 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -8.87% | 1,861,167 | - |
| 141 | KOD | Kodiak Sciences Inc. | 1.17B | -7.42% | 362,558 | - |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.16B | -3.22% | 620,848 | - |
| 143 | PGEN | Precigen, Inc. | 1.16B | -7.63% | 4,022,065 | 6.31M |
| 144 | EYPT | EyePoint, Inc. | 1.14B | -1.87% | 939,239 | 31.37M |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | -10.02% | 1,247,555 | - |
| 146 | SEPN | Septerna, Inc. | 1.08B | -4.21% | 232,076 | 45.95M |
| 147 | TVGN | Tevogen Bio Holdings Inc. | 1.08B | 3.09% | 38,009 | - |
| 148 | ABCL | AbCellera Biologics Inc. | 1.07B | -0.85% | 1,468,815 | 75.13M |
| 149 | PHAR | Pharming Group N.V. | 1.05B | -1.48% | 8,531 | 376.13M |
| 150 | SVRA | Savara Inc. | 1.03B | -2.14% | 1,900,360 | - |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.01B | -4.71% | 455,233 | - |
| 152 | AVBP | ArriVent BioPharma, Inc. | 1.01B | -5.00% | 489,501 | - |
| 153 | INBX | Inhibrx Biosciences, Inc. | 999.01M | -1.46% | 164,097 | 1.40M |
| 154 | GERN | Geron Corporation | 992.84M | -4.32% | 15,074,043 | 183.88M |
| 155 | VALN | Valneva SE | 970.26M | 1.63% | 33,830 | 205.07M |
| 156 | AKTS | Aktis Oncology, Inc. | 960.11M | -4.94% | 466,836 | 5.56M |
| 157 | CMPX | Compass Therapeutics, Inc. | 958.07M | -2.39% | 1,487,376 | 850.00K |
| 158 | XERS | Xeris Biopharma Holdings, Inc. | 936.30M | -3.21% | 1,376,762 | 291.85M |
| 159 | GHRS | GH Research PLC | 931.68M | -2.21% | 102,561 | - |
| 160 | FTRE | Fortrea Holdings Inc. | 929.39M | 2.47% | 1,636,640 | 2.72B |
| 161 | QURE | uniQure N.V. | 921.06M | -5.70% | 1,944,062 | 16.10M |
| 162 | URGN | UroGen Pharma Ltd. | 899.65M | -0.59% | 920,003 | 109.79M |
| 163 | SGP | SpyGlass Pharma, Inc. | 891.57M | -1.62% | 174,630 | - |
| 164 | EVMN | Evommune, Inc. | 867.68M | -3.76% | 291,587 | 13.00M |
| 165 | PHAT | Phathom Pharmaceuticals, Inc. | 863.63M | 1.01% | 664,760 | 175.11M |
| 166 | XNCR | Xencor, Inc. | 849.99M | -1.28% | 746,624 | 125.58M |
| 167 | JANX | Janux Therapeutics, Inc. | 843.13M | -1.35% | 737,687 | 10.00M |
| 168 | SANA | Sana Biotechnology, Inc. | 835.29M | -2.80% | 2,173,669 | - |
| 169 | IVA | Inventiva S.A. | 829.34M | -3.25% | 293,220 | 19.93M |
| 170 | SPRY | ARS Pharmaceuticals, Inc. | 824.17M | -6.64% | 1,467,517 | 84.28M |
| 171 | ANL | Adlai Nortye Ltd. | 820.29M | -7.61% | 112,505 | -1.35M |
| 172 | ABUS | Arbutus Biopharma Corporation | 817.38M | -2.52% | 1,309,152 | 14.61M |
| 173 | MNKD | MannKind Corporation | 804.14M | -4.40% | 4,763,329 | 348.97M |
| 174 | CGEM | Cullinan Therapeutics, Inc. | 794.71M | -2.31% | 568,518 | - |
| 175 | KALV | KalVista Pharmaceuticals, Inc. | 782.96M | -6.46% | 787,905 | 1.43M |
| 176 | OMER | Omeros Corporation | 776.36M | -2.84% | 783,939 | - |
| 177 | OCGN | Ocugen, Inc. | 750.88M | -6.53% | 11,422,637 | 4.41M |
| 178 | CTMX | CytomX Therapeutics, Inc. | 748.82M | -19.27% | 40,720,582 | 76.20M |
| 179 | MPLT | MapLight Therapeutics, Inc. | 742.78M | -4.76% | 286,887 | - |
| 180 | KURA | Kura Oncology, Inc. | 741.09M | -2.21% | 934,242 | 67.48M |
| 181 | ANRO | Alto Neuroscience, Inc. | 719.41M | 0.72% | 296,070 | - |
| 182 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.69M | -6.33% | 167,352 | - |
| 183 | SLS | SELLAS Life Sciences Group, Inc. | 705.09M | -1.79% | 5,399,552 | - |
| 184 | TBPH | Theravance Biopharma, Inc. | 700.80M | -0.65% | 538,358 | 80.33M |
| 185 | ARVN | Arvinas, Inc. | 696.54M | -9.33% | 1,715,914 | 262.60M |
| 186 | DRUG | Bright Minds Biosciences Inc. | 690.76M | -3.16% | 78,702 | - |
| 187 | GYRE | Gyre Therapeutics, Inc. | 679.71M | -8.37% | 190,243 | 116.59M |
| 188 | JBIO | Jade Biosciences, Inc. | 679.58M | -1.36% | 453,769 | - |
| 189 | AGMB | AgomAb Therapeutics NV | 675.00M | 1.02% | 53,203 | - |
| 190 | LXRX | Lexicon Pharmaceuticals, Inc. | 660.94M | -3.70% | 1,392,919 | 49.80M |
| 191 | ANNX | Annexon, Inc. | 648.41M | -3.39% | 2,807,943 | - |
| 192 | DRTS | Alpha Tau Medical Ltd. | 643.35M | -2.14% | 288,270 | - |
| 193 | PRME | Prime Medicine, Inc. | 637.35M | -4.85% | 2,322,630 | 4.63M |
| 194 | DSGN | Design Therapeutics, Inc. | 635.22M | -6.70% | 354,348 | - |
| 195 | EIKN | Eikon Therapeutics, Inc. | 633.78M | -8.57% | 500,346 | - |
| 196 | MDXG | MiMedx Group, Inc. | 629.92M | -2.75% | 824,792 | 418.63M |
| 197 | TECX | Tectonic Therapeutic, Inc. | 603.67M | 2.13% | 201,269 | - |
| 198 | LBRX | LB Pharmaceuticals Inc | 601.11M | -2.70% | 309,154 | - |
| 199 | MGTX | MeiraGTx Holdings plc | 598.05M | -2.88% | 482,000 | 27.42M |
| 200 | ZVRA | Zevra Therapeutics, Inc. | 560.70M | -3.54% | 956,624 | 106.47M |
| 201 | REPL | Replimune Group, Inc. | 558.19M | -3.43% | 1,419,731 | - |
| 202 | SLDB | Solid Biosciences Inc. | 554.72M | -8.25% | 1,081,814 | - |
| 203 | DBVT | DBV Technologies S.A. | 532.40M | -1.97% | 180,359 | 5.50M |
| 204 | ALLO | Allogene Therapeutics, Inc. | 524.12M | -5.29% | 5,536,403 | 22.00K |
| 205 | ADCT | ADC Therapeutics SA | 509.45M | -2.43% | 642,215 | 81.36M |
| 206 | VNDA | Vanda Pharmaceuticals Inc. | 505.96M | -0.47% | 1,642,774 | 216.11M |
| 207 | CRMD | CorMedix Inc. | 503.55M | -1.39% | 1,348,285 | 311.71M |
| 208 | VSTM | Verastem, Inc. | 488.36M | -1.94% | 2,084,000 | 30.91M |
| 209 | RCKT | Rocket Pharmaceuticals, Inc. | 485.30M | -3.46% | 2,224,828 | - |
| 210 | ENGN | enGene Holdings Inc. | 480.98M | -0.97% | 1,084,742 | - |
| 211 | AVIR | Atea Pharmaceuticals, Inc. | 470.86M | -3.59% | 686,383 | - |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 469.96M | -3.56% | 373,733 | 294.28M |
| 213 | UPB | Upstream Bio, Inc. | 468.24M | -10.76% | 719,394 | 2.80M |
| 214 | LYEL | Lyell Immunopharma, Inc. | 467.54M | -0.40% | 86,336 | 36.00K |
| 215 | EPRX | Eupraxia Pharmaceuticals Inc. | 463.09M | -0.92% | 238,346 | - |
| 216 | PRTA | Prothena Corporation plc | 462.43M | -4.56% | 495,808 | 9.68M |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 460.87M | -6.86% | 1,312,243 | 80.00M |
| 218 | CTNM | Contineum Therapeutics, Inc. | 456.25M | -7.53% | 451,436 | - |
| 219 | RLMD | Relmada Therapeutics, Inc. | 455.40M | -3.72% | 1,459,647 | - |
| 220 | TRDA | Entrada Therapeutics, Inc. | 454.82M | -5.64% | 159,749 | 25.42M |
| 221 | MRVI | Maravai LifeSciences Holdings, Inc. | 446.47M | -2.24% | 3,116,170 | 185.74M |
| 222 | YDES | YD Bio Limited | 445.83M | -10.83% | 20,539 | 510.36K |
| 223 | ALT | Altimmune, Inc. | 444.84M | -3.12% | 3,477,122 | 41.00K |
| 224 | ACRS | Aclaris Therapeutics, Inc. | 441.38M | -5.67% | 1,495,029 | 7.83M |
| 225 | NMRA | Neumora Therapeutics, Inc. | 441.12M | -6.71% | 790,238 | - |
| 226 | FDMT | 4D Molecular Therapeutics, Inc. | 437.00M | -0.58% | 534,656 | 85.21M |
| 227 | ASMB | Assembly Biosciences, Inc. | 435.29M | -3.54% | 42,013 | 37.19M |
| 228 | STTK | Shattuck Labs, Inc. | 432.25M | 1.51% | 1,510,999 | 1.00M |
| 229 | ABSI | Absci Corporation | 430.06M | -5.61% | 6,833,511 | 2.82M |
| 230 | RGNX | REGENXBIO Inc. | 427.36M | -4.17% | 641,187 | 170.44M |
| 231 | IVVD | Invivyd, Inc. | 426.72M | -5.03% | 2,132,555 | 53.43M |
| 232 | LXEO | Lexeo Therapeutics, Inc. | 420.04M | -9.80% | 827,749 | - |
| 233 | AURA | Aura Biosciences, Inc. | 417.85M | -3.38% | 305,311 | - |
| 234 | IPSC | Century Therapeutics, Inc. | 413.36M | 0.44% | 1,889,561 | 109.16M |
| 235 | BNTC | Benitec Biopharma Inc. | 401.26M | -0.60% | 187,570 | - |
| 236 | AVXL | Anavex Life Sciences Corp. | 394.78M | -6.37% | 907,871 | - |
| 237 | PRTC | PureTech Health plc | 390.65M | -0.91% | 2,736 | 6.39M |
| 238 | MNPR | Monopar Therapeutics Inc. | 389.59M | -3.27% | 314,698 | - |
| 239 | ZURA | Zura Bio Limited | 389.49M | -6.99% | 588,259 | - |
| 240 | AUTL | Autolus Therapeutics plc | 385.91M | -3.97% | 952,386 | 51.13M |
| 241 | DNA | Ginkgo Bioworks Holdings, Inc. | 382.42M | -4.98% | 827,400 | 170.16M |
| 242 | KYTX | Kyverna Therapeutics, Inc. | 374.02M | -2.95% | 537,413 | - |
| 243 | LCTX | Lineage Cell Therapeutics, Inc. | 373.63M | -5.06% | 937,053 | 14.56M |
| 244 | DMAC | DiaMedica Therapeutics Inc. | 370.79M | -0.56% | 357,296 | - |
| 245 | GLSI | Greenwich LifeSciences, Inc. | 370.05M | -11.11% | 168,059 | - |
| 246 | CADL | Candel Therapeutics, Inc. | 369.16M | -2.51% | 1,017,381 | - |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 368.55M | -4.30% | 130,633 | 66.98M |
| 248 | XFOR | X4 Pharmaceuticals, Inc. | 368.22M | -4.26% | 559,199 | 35.11M |
| 249 | LRMR | Larimar Therapeutics, Inc. | 368.04M | -1.83% | 1,119,669 | - |
| 250 | LENZ | LENZ Therapeutics, Inc. | 366.72M | -6.24% | 996,433 | 17.50M |
| 251 | NAGE | Niagen Bioscience, Inc. | 364.37M | -4.61% | 1,103,733 | 129.42M |
| 252 | PEPG | PepGen Inc. | 353.87M | 0.59% | 327,482 | - |
| 253 | NAUT | Nautilus Biotechnology, Inc. | 346.08M | 3.40% | 213,113 | - |
| 254 | CLYM | Climb Bio, Inc. | 340.11M | - | 484,776 | - |
| 255 | NERV | Minerva Neurosciences, Inc. | 336.67M | -1.02% | 512,971 | - |
| 256 | IRD | Opus Genetics, Inc. | 331.55M | -2.92% | 926,598 | 14.20M |
| 257 | BCYC | Bicycle Therapeutics plc | 327.62M | -7.30% | 751,102 | 72.59M |
| 258 | XOMA | XOMA Royalty Corporation | 325.62M | 1.30% | 122,777 | 52.15M |
| 259 | NBP | NovaBridge Biosciences | 325.12M | -2.08% | 841,197 | - |
| 260 | IMMX | Immix Biopharma, Inc. | 317.65M | -14.93% | 1,466,524 | - |
| 261 | ACIU | AC Immune SA | 314.48M | -6.93% | 220,853 | 4.51M |
| 262 | SLN | Silence Therapeutics plc | 313.16M | -4.05% | 287,382 | 559.00K |
| 263 | FBRX | Forte Biosciences, Inc. | 311.29M | -6.01% | 191,075 | - |
| 264 | ARMP | Armata Pharmaceuticals, Inc. | 310.26M | -11.13% | 29,587 | 5.05M |
| 265 | IMRX | Immuneering Corporation | 309.04M | -0.42% | 1,207,850 | - |
| 266 | PBYI | Puma Biotechnology, Inc. | 305.26M | -2.28% | 235,388 | 228.37M |
| 267 | OVID | Ovid Therapeutics Inc. | 303.31M | 14.43% | 40,774,255 | 7.25M |
| 268 | NGNE | Neurogene Inc. | 302.05M | -7.50% | 169,239 | 925.00K |
| 269 | PROK | ProKidney Corp. | 295.24M | -2.35% | 366,377 | 893.00K |
| 270 | PALI | Palisade Bio, Inc. | 293.54M | -1.01% | 4,301,902 | - |
| 271 | FHTX | Foghorn Therapeutics Inc. | 286.46M | -3.56% | 231,571 | 30.91M |
| 272 | CABA | Cabaletta Bio, Inc. | 285.91M | -4.19% | 3,198,745 | - |
| 273 | CBIO | Crescent Biopharma, Inc. | 285.21M | -6.76% | 259,322 | 10.84M |
| 274 | TARA | Protara Therapeutics, Inc. | 285.02M | -3.30% | 518,044 | - |
| 275 | ALXO | ALX Oncology Holdings Inc. | 282.96M | -0.92% | 800,191 | - |
| 276 | CAMP | Camp4 Therapeutics Corporation | 276.73M | -3.96% | 68,709 | 3.50M |
| 277 | CNTX | Context Therapeutics Inc. | 268.29M | 2.10% | 608,890 | - |
| 278 | TENX | Tenax Therapeutics, Inc. | 267.68M | 2.60% | 449,198 | - |
| 279 | AVTX | Avalo Therapeutics, Inc. | 266.21M | -4.55% | 409,566 | 192.00K |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 263.93M | -2.17% | 300,772 | 33.48M |
| 281 | OABI | OmniAb, Inc. | 263.50M | -0.55% | 355,888 | 18.67M |
| 282 | CCCC | C4 Therapeutics, Inc. | 262.49M | -2.54% | 2,514,553 | 35.95M |
| 283 | PLYX | Polaryx Therapeutics, Inc. | 261.81M | -1.78% | 709,372 | - |
| 284 | ABEO | Abeona Therapeutics Inc. | 259.57M | -4.41% | 2,854,921 | 5.82M |
| 285 | CLLS | Cellectis S.A. | 256.67M | 0.58% | 26,974 | 82.55M |
| 286 | HELP | Cybin Inc. | 237.67M | -2.26% | 487,495 | - |
| 287 | CHRS | Coherus Oncology, Inc. | 236.83M | -5.95% | 1,401,830 | 42.17M |
| 288 | EDIT | Editas Medicine, Inc. | 230.00M | -4.47% | 1,112,677 | 40.52M |
| 289 | RZLT | Rezolute, Inc. | 227.76M | -7.03% | 1,803,864 | - |
| 290 | ALEC | Alector, Inc. | 226.24M | -8.07% | 558,963 | 21.05M |
| 291 | VYGR | Voyager Therapeutics, Inc. | 224.09M | -4.08% | 616,082 | 40.37M |
| 292 | SRZN | Surrozen, Inc. | 220.11M | 0.31% | 57,950 | 3.60M |
| 293 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 218.51M | -19.40% | 991,527 | - |
| 294 | MDWD | MediWound Ltd. | 218.20M | -2.30% | 46,147 | 16.96M |
| 295 | NVCT | Nuvectis Pharma, Inc. | 217.76M | -5.63% | 80,830 | - |
| 296 | KROS | Keros Therapeutics, Inc. | 215.91M | -3.44% | 394,814 | 244.06M |
| 297 | ACHV | Achieve Life Sciences, Inc. | 215.07M | -4.94% | 315,167 | - |
| 298 | ELTX | Elicio Therapeutics, Inc. | 214.87M | -4.11% | 210,068 | - |
| 299 | FENC | Fennec Pharmaceuticals Inc. | 210.03M | -3.74% | 225,563 | 38.79M |
| 300 | SLGL | Sol-Gel Technologies Ltd. | 209.88M | -5.53% | 23,501 | 18.97M |
| 301 | CGEN | Compugen Ltd. | 205.18M | -4.41% | 265,313 | 72.76M |
| 302 | HUMA | Humacyte, Inc. | 198.51M | -8.62% | 4,306,145 | 1.57M |
| 303 | PRLD | Prelude Therapeutics Incorporated | 196.57M | -9.04% | 97,747 | 12.14M |
| 304 | CBUS | Cibus, Inc. | 191.67M | -24.73% | 1,079,879 | 3.64M |
| 305 | TNXP | Tonix Pharmaceuticals Holding Corp. | 190.22M | -5.15% | 335,379 | 13.11M |
| 306 | MGNX | MacroGenics, Inc. | 189.40M | -3.25% | 921,845 | 149.50M |
| 307 | SABS | SAB Biotherapeutics, Inc. | 188.52M | -9.09% | 3,434,446 | 114.70K |
| 308 | ARCT | Arcturus Therapeutics Holdings Inc. | 186.17M | 2.50% | 554,877 | 82.03M |
| 309 | ADAG | Adagene Inc. | 185.70M | 0.77% | 125,338 | 103.20K |
| 310 | STRO | Sutro Biopharma, Inc. | 185.47M | -5.03% | 220,062 | 105.65M |
| 311 | CRBU | Caribou Biosciences, Inc. | 184.58M | -3.05% | 1,027,536 | 11.16M |
| 312 | NTHI | NeOnc Technologies Holdings, Inc. | 184.03M | -8.47% | 44,480 | 59.99K |
| 313 | ZNTL | Zentalis Pharmaceuticals, Inc. | 181.71M | -7.88% | 587,169 | 26.87M |
| 314 | GALT | Galectin Therapeutics Inc. | 181.49M | -10.63% | 399,525 | - |
| 315 | PRQR | ProQR Therapeutics N.V. | 181.22M | -2.82% | 215,709 | 19.19M |
| 316 | CNTN | Canton Strategic Holdings, Inc. | 180.57M | -11.27% | 1,004,996 | - |
| 317 | WHWK | Whitehawk Therapeutics, Inc. | 179.82M | -3.54% | 127,701 | 7.15M |
| 318 | ELDN | Eledon Pharmaceuticals, Inc. | 179.80M | 4.17% | 2,107,237 | - |
| 319 | TNYA | Tenaya Therapeutics, Inc. | 178.48M | -4.07% | 2,277,664 | - |
| 320 | PLX | Protalix BioTherapeutics, Inc. | 177.73M | -20.79% | 3,358,964 | 52.74M |
| 321 | ABOS | Acumen Pharmaceuticals, Inc. | 176.87M | -5.50% | 529,020 | - |
| 322 | RNAC | Cartesian Therapeutics, Inc. | 176.29M | -7.38% | 161,256 | 2.80M |
| 323 | DTIL | Precision BioSciences, Inc. | 173.83M | 1.44% | 1,100,367 | 34.26M |
| 324 | MIST | Milestone Pharmaceuticals Inc. | 172.69M | -4.49% | 772,941 | - |
| 325 | KLRS | Kalaris Therapeutics, Inc. | 172.65M | -11.62% | 63,158 | - |
| 326 | MOLN | Molecular Partners AG | 170.04M | 4.72% | 6,874 | 856.30K |
| 327 | NBY | NovaBay Pharmaceuticals, Inc. | 167.20M | -5.88% | 225,610 | 10.30M |
| 328 | ANTX | AN2 Therapeutics, Inc. | 166.05M | -7.60% | 395,257 | - |
| 329 | KRRO | Korro Bio, Inc. | 164.56M | -7.31% | 202,545 | 6.39M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 160.51M | -6.02% | 192,406 | - |
| 331 | NKTX | Nkarta, Inc. | 159.11M | -3.45% | 820,511 | - |
| 332 | HRTX | Heron Therapeutics, Inc. | 158.37M | -3.04% | 2,169,223 | 154.90M |
| 333 | SGMT | Sagimet Biosciences Inc. | 158.36M | -6.36% | 418,262 | - |
| 334 | EVAX | Evaxion A/S | 157.63M | -1.31% | 51,122 | 7.53M |
| 335 | KPTI | Karyopharm Therapeutics Inc. | 154.09M | 0.24% | 501,656 | 146.07M |
| 336 | PMN | ProMIS Neurosciences, Inc. | 152.45M | -13.04% | 28,030 | - |
| 337 | CNTB | Connect Biopharma Holdings Limited | 152.06M | 0.37% | 157,333 | 762.00K |
| 338 | IMUX | Immunic, Inc. | 150.03M | -4.17% | 1,202,971 | - |
| 339 | VXRT | Vaxart, Inc. | 149.15M | -8.18% | - | 237.26M |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 145.28M | -3.15% | 460,892 | - |
| 341 | AGEN | Agenus Inc. | 144.38M | -5.76% | 1,010,576 | 114.20M |
| 342 | ARTV | Artiva Biotherapeutics, Inc. | 143.36M | -8.23% | 229,722 | 251.00K |
| 343 | VTVT | vTv Therapeutics Inc. | 142.97M | -1.09% | 43,064 | 17.00K |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 142.09M | -1.11% | 65,706 | 2.00M |
| 345 | SPRO | Spero Therapeutics, Inc. | 138.59M | -4.65% | 351,569 | 40.55M |
| 346 | IKT | Inhibikase Therapeutics, Inc. | 137.57M | -6.63% | 1,082,270 | 1.00 |
| 347 | VOR | Vor Biopharma Inc. | 135.34M | -5.25% | 1,012,573 | - |
| 348 | CDXS | Codexis, Inc. | 133.58M | - | 1,853,379 | 70.39M |
| 349 | MENS | Jyong Biotech Ltd. | 132.88M | -0.56% | 224,254 | - |
| 350 | EQ | Equillium, Inc. | 129.70M | -0.93% | 402,807 | 4.39M |
| 351 | ACOG | Alpha Cognition Inc. | 125.02M | -0.17% | 12,990 | 7.43M |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 124.32M | -2.69% | 464,888 | 70.00M |
| 353 | CRDF | Cardiff Oncology, Inc. | 123.74M | -5.73% | 549,737 | 593.00K |
| 354 | FATE | Fate Therapeutics, Inc. | 123.24M | -6.19% | 1,516,250 | 6.65M |
| 355 | IPHA | Innate Pharma S.A. | 122.77M | -2.24% | 11,544 | 14.84M |
| 356 | SGMO | Sangamo Therapeutics, Inc. | 121.14M | -5.26% | 8,312,318 | 32.88M |
| 357 | RANI | Rani Therapeutics Holdings, Inc. | 116.07M | -9.16% | 2,566,583 | 1.20M |
| 358 | INO | Inovio Pharmaceuticals, Inc. | 114.69M | -1.19% | 574,780 | 65.34K |
| 359 | AARD | Aardvark Therapeutics, Inc. | 106.25M | -8.44% | 382,539 | - |
| 360 | COYA | Coya Therapeutics, Inc. | 104.38M | 1.14% | 248,967 | 7.95M |
| 361 | ONCY | Oncolytics Biotech Inc. | 103.36M | -3.06% | 595,969 | - |
| 362 | TTRX | Turn Therapeutics Inc. | 102.47M | -3.87% | 14,590 | - |
| 363 | GOSS | Gossamer Bio, Inc. | 101.88M | -7.99% | 10,906,013 | 48.47M |
| 364 | GNLX | Genelux Corporation | 98.55M | -1.15% | 132,029 | 8.00K |
| 365 | SEER | Seer, Inc. | 98.17M | -2.25% | 307,156 | 16.58M |
| 366 | VRCA | Verrica Pharmaceuticals Inc. | 98.09M | -9.51% | 113,853 | 35.58M |
| 367 | FBIO | Fortress Biotech, Inc. | 98.08M | 1.28% | 215,660 | 62.30M |
| 368 | CGTX | Cognition Therapeutics, Inc. | 97.10M | -4.35% | 893,803 | - |
| 369 | HURA | TuHURA Biosciences, Inc. | 96.37M | -9.62% | 798,146 | - |
| 370 | PYXS | Pyxis Oncology, Inc. | 95.26M | -5.56% | 944,432 | 2.82M |
| 371 | CING | Cingulate Inc. | 93.49M | -31.05% | 2,212,914 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 92.87M | -4.15% | 95,056 | - |
| 373 | MCRB | Seres Therapeutics, Inc. | 86.56M | -3.83% | 58,716 | 789.00K |
| 374 | ALDX | Aldeyra Therapeutics, Inc. | 85.46M | 14.52% | 16,700,666 | - |
| 375 | VANI | Vivani Medical, Inc. | 85.35M | -3.31% | 105,047 | - |
| 376 | QTTB | Q32 Bio Inc. | 85.00M | -5.22% | 178,901 | 53.74M |
| 377 | BMEA | Biomea Fusion, Inc. | 82.72M | -4.10% | 1,318,654 | - |
| 378 | KZIA | Kazia Therapeutics Limited | 81.83M | -0.27% | 185,299 | 1.20M |
| 379 | CSBR | Champions Oncology, Inc. | 80.96M | -5.97% | 16,782 | 57.95M |
| 380 | SPRB | Spruce Biosciences, Inc. | 80.61M | -8.63% | 26,338 | 697.00K |
| 381 | PYPD | PolyPid Ltd. | 79.92M | -3.73% | 50,561 | - |
| 382 | ATYR | aTyr Pharma, Inc. | 79.91M | -7.54% | 801,340 | 190.00K |
| 383 | PMVP | PMV Pharmaceuticals, Inc. | 79.46M | -4.49% | 560,997 | - |
| 384 | PLRX | Pliant Therapeutics, Inc. | 79.25M | -3.76% | 504,810 | - |
| 385 | PTHS | Pelthos Therapeutics Inc. | 77.91M | 0.96% | 4,716 | 7.41M |
| 386 | IBIO | iBio, Inc. | 75.65M | -10.98% | 615,665 | 300.00K |
| 387 | NRXS | NeurAxis, Inc. | 74.46M | -3.05% | 400,836 | 3.36M |
| 388 | BYSI | BeyondSpring Inc. | 72.19M | - | 44,684 | 1.88M |
| 389 | GANX | Gain Therapeutics, Inc. | 70.39M | -25.57% | 3,086,359 | - |
| 390 | ANVS | Annovis Bio, Inc. | 70.04M | -9.85% | 658,290 | - |
| 391 | MNOV | MediciNova, Inc. | 69.40M | -4.08% | 66,212 | 409.66K |
| 392 | GRCE | Grace Therapeutics, Inc. | 68.70M | -0.22% | 484,417 | - |
| 393 | XBIT | XBiotech Inc. | 68.60M | - | 49,323 | - |
| 394 | ACET | Adicet Bio, Inc. | 66.50M | -3.62% | 331,548 | - |
| 395 | EDSA | Edesa Biotech, Inc. | 64.20M | 9.86% | 1,618,456 | - |
| 396 | ATHE | Alterity Therapeutics Limited | 63.44M | 4.79% | 3,500 | 4.43M |
| 397 | IMA | ImageneBio, Inc. | 62.06M | -3.24% | 24,323 | 800.00K |
| 398 | ENTX | Entera Bio Ltd. | 61.45M | -2.90% | 101,253 | 124.00K |
| 399 | IMMP | Immutep Limited | 60.99M | 2.59% | 2,355,851 | 5.28M |
| 400 | GUTS | Fractyl Health, Inc. | 60.97M | -3.11% | 1,649,629 | 3.00K |
| 401 | TCRX | TScan Therapeutics, Inc. | 60.88M | -1.83% | 532,921 | 10.33M |
| 402 | EXOZ | eXoZymes, Inc. | 59.80M | -2.46% | 1,167 | -700.00 |
| 403 | IFRX | InflaRx N.V. | 59.62M | -3.64% | 1,021,935 | 73.73K |
| 404 | COEP | Coeptis Therapeutics Holdings, Inc. | 59.33M | -5.04% | 55,898 | 501.00K |
| 405 | ACTU | Actuate Therapeutics, Inc. | 58.57M | -9.03% | 63,936 | - |
| 406 | HYFT | MindWalk Holdings Corp. | 57.61M | -5.69% | 209,684 | 20.70M |
| 407 | TIL | Instil Bio, Inc. | 56.49M | -2.80% | 24,893 | - |
| 408 | MREO | Mereo BioPharma Group plc | 55.97M | -6.21% | 1,800,264 | 500.00K |
| 409 | RADX | Radiopharm Theranostics Limited | 55.53M | -3.29% | 34,558 | 10.86M |
| 410 | MAIA | MAIA Biotechnology, Inc. | 55.18M | -0.67% | 813,728 | - |
| 411 | OKUR | OnKure Therapeutics, Inc. | 54.83M | -0.25% | 175,551 | - |
| 412 | ICCC | ImmuCell Corporation | 54.64M | -0.17% | 7,265 | 27.64M |
| 413 | MGX | Metagenomi Therapeutics, Inc. | 54.17M | -1.37% | 211,608 | 25.21M |
| 414 | NRXP | NRx Pharmaceuticals, Inc. | 53.39M | -2.56% | 587,083 | 242.00K |
| 415 | LPCN | Lipocine Inc. | 53.29M | -4.82% | 69,200 | 1.98M |
| 416 | OSTX | OS Therapies Incorporated | 53.17M | -1.31% | 299,928 | - |
| 417 | ACRV | Acrivon Therapeutics, Inc. | 51.75M | -1.20% | 505,131 | - |
| 418 | DCOY | Decoy Therapeutics Inc. | 50.72M | -1.61% | 12,440 | - |
| 419 | KZR | Kezar Life Sciences, Inc. | 49.87M | - | 5,454 | - |
| 420 | RLYB | Rallybio Corporation | 49.51M | -3.01% | 90,568 | 858.00K |
| 421 | IBO | Impact BioMedical Inc. | 49.08M | 3.22% | 497,819 | 32.00K |
| 422 | NTRB | Nutriband Inc. | 47.30M | 0.51% | 5,796 | 2.28M |
| 423 | LSTA | Lisata Therapeutics, Inc. | 45.25M | -0.40% | 160,104 | 170.00K |
| 424 | INKT | MiNK Therapeutics, Inc. | 44.41M | -1.15% | 62,703 | - |
| 425 | ATOS | Atossa Therapeutics, Inc. | 44.00M | -6.92% | 47,150 | - |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | -5.93% | 136,722 | - |
| 427 | ALGS | Aligos Therapeutics, Inc. | 43.01M | -4.79% | 28,593 | 2.19M |
| 428 | LITS | Lite Strategy, Inc. | 42.91M | -2.48% | 186,828 | - |
| 429 | GOVX | GeoVax Labs, Inc. | 42.68M | -15.48% | 169,047 | 3.35M |
| 430 | APLM | Apollomics, Inc. | 41.87M | - | 1,701 | 6.93M |
| 431 | CMMB | Chemomab Therapeutics Ltd. | 41.39M | -2.91% | 25,777 | - |
| 432 | NXTC | NextCure, Inc. | 41.34M | -5.76% | 66,450 | - |
| 433 | PTN | Palatin Technologies, Inc. | 41.01M | -7.53% | 11,132 | 8.96M |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 40.92M | -3.11% | 277,620 | 1.14M |
| 435 | ATRA | Atara Biotherapeutics, Inc. | 40.89M | -4.40% | 135,619 | 120.77M |
| 436 | ESLA | Estrella Immunopharma, Inc. | 40.79M | -2.70% | 98,883 | - |
| 437 | PSTV | Plus Therapeutics, Inc. | 40.49M | -5.60% | 4,248,022 | 5.21M |
| 438 | CRVO | CervoMed Inc. | 39.26M | -6.40% | 85,588 | 4.01M |
| 439 | LONA | LeonaBio, Inc. | 38.57M | -13.45% | 464,006 | - |
| 440 | SNSE | Sensei Biotherapeutics, Inc. | 38.52M | 1.73% | 119,532 | - |
| 441 | RNXT | RenovoRx, Inc. | 37.75M | 6.59% | 865,074 | 928.00K |
| 442 | VERU | Veru Inc. | 36.92M | -4.56% | 105,144 | 16.89M |
| 443 | CELU | Celularity Inc. | 36.05M | -0.79% | 45,231 | 40.58M |
| 444 | RNTX | Rein Therapeutics Inc. | 35.22M | -5.63% | 79,833 | - |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 34.32M | -3.51% | 117,114 | 90.00K |
| 446 | JSPR | Jasper Therapeutics, Inc. | 34.14M | -2.40% | 257,863 | - |
| 447 | PLUR | Pluri Inc. | 33.07M | 1.86% | 5,119 | 1.34M |
| 448 | INMB | INmune Bio Inc. | 32.97M | -3.13% | 345,773 | 50.00K |
| 449 | TVRD | Tvardi Therapeutics, Inc. | 32.27M | -5.49% | 57,222 | - |
| 450 | PDSB | PDS Biotechnology Corporation | 31.82M | -5.86% | 463,578 | - |
| 451 | BCTX | BriaCell Therapeutics Corp. | 31.35M | -5.27% | 292,306 | - |
| 452 | ABVC | ABVC BioPharma, Inc. | 31.04M | -6.39% | 46,160 | 797.92K |
| 453 | HYPD | Hyperion DeFi, Inc. | 30.53M | 0.27% | 937,147 | 345.32K |
| 454 | CVM | CEL-SCI Corporation | 30.36M | -0.28% | 35,173 | - |
| 455 | TLSA | Tiziana Life Sciences Ltd | 29.94M | -3.08% | 81,383 | - |
| 456 | TPST | Tempest Therapeutics, Inc. | 29.12M | -4.85% | 28,619 | - |
| 457 | OTLK | Outlook Therapeutics, Inc. | 29.07M | -11.55% | 2,121,197 | 205.70K |
| 458 | KYNB | Kyntra Bio, Inc. | 28.53M | -4.34% | 53,549 | 6.44M |
| 459 | XLO | Xilio Therapeutics, Inc. | 28.50M | - | 30,070 | 31.80M |
| 460 | XCUR | Exicure, Inc. | 28.24M | -2.42% | 22,393 | 500.00K |
| 461 | DYAI | Dyadic International, Inc. | 28.23M | -2.76% | 20,792 | 3.34M |
| 462 | BOLD | Boundless Bio, Inc. | 26.22M | 2.17% | 55,216 | - |
| 463 | BRNS | Barinthus Biotherapeutics plc | 26.10M | -6.03% | 5,137 | 14.97M |
| 464 | ENLV | Enlivex Ltd. | 26.01M | -0.91% | 246,729 | - |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 25.87M | -5.36% | 166,263 | - |
| 466 | CUE | Cue Biopharma, Inc. | 25.82M | -2.62% | 1,235,915 | 27.47M |
| 467 | LTRN | Lantern Pharma Inc. | 25.61M | -1.72% | 22,414 | - |
| 468 | IGC | IGC Pharma, Inc. | 25.59M | -4.67% | 286,194 | 1.11M |
| 469 | SNTI | Senti Biosciences, Inc. | 25.51M | -0.99% | 76,572 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 24.64M | -0.87% | 20,218 | 14.99M |
| 471 | NNVC | NanoViricides, Inc. | 24.19M | -0.88% | 188,232 | - |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 24.17M | -5.63% | 443,951 | 789.00K |
| 473 | LGVN | Longeveron Inc. | 22.71M | 1.69% | 2,196,397 | 1.20M |
| 474 | PASG | Passage Bio, Inc. | 22.55M | -4.48% | 23,685 | - |
| 475 | SKYE | Skye Bioscience, Inc. | 22.47M | 0.48% | 257,561 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.34M | -1.47% | 74,402 | 4.69M |
| 477 | DARE | Daré Bioscience, Inc. | 20.00M | -3.45% | 47,228 | -57.13K |
| 478 | VYNE | VYNE Therapeutics Inc. | 19.32M | -4.52% | 152,088 | 570.00K |
| 479 | KTTA | Pasithea Therapeutics Corp. | 18.93M | -4.12% | 76,552 | - |
| 480 | LEXX | Lexaria Bioscience Corp. | 18.54M | 1.83% | 126,059 | 522.00K |
| 481 | ALLR | Allarity Therapeutics, Inc. | 18.50M | -6.40% | 105,557 | - |
| 482 | CTXR | Citius Pharmaceuticals, Inc. | 18.47M | 1.80% | 634,481 | 3.94M |
| 483 | INAB | IN8bio, Inc. | 18.12M | -3.66% | 45,460 | - |
| 484 | FBLG | FibroBiologics, Inc. | 17.61M | -5.68% | 1,294,294 | - |
| 485 | INTS | Intensity Therapeutics, Inc. | 16.42M | -0.15% | 13,465 | - |
| 486 | LIXT | Lixte Biotechnology Holdings, Inc. | 16.09M | -6.31% | 4,691 | - |
| 487 | TRAW | Traws Pharma, Inc. | 15.90M | -9.54% | 42,329 | 2.85M |
| 488 | AEON | AEON Biopharma, Inc. | 15.73M | -1.72% | 26,096 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 15.58M | 1.80% | 61,652 | - |
| 490 | ARTL | Artelo Biosciences, Inc. | 15.53M | 50.72% | 58,783,596 | - |
| 491 | HOTH | Hoth Therapeutics, Inc. | 15.36M | -4.81% | 237,020 | - |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 15.03M | -3.98% | 33,814 | - |
| 493 | ACXP | Acurx Pharmaceuticals, Inc. | 14.87M | 6.76% | 980,760 | - |
| 494 | PLRZ | Polyrizon Ltd. | 14.12M | 5.96% | 25,201 | - |
| 495 | PHIO | Phio Pharmaceuticals Corp. | 13.94M | -5.51% | 228,243 | - |
| 496 | CLRB | Cellectar Biosciences, Inc. | 13.78M | -1.52% | 22,419 | - |
| 497 | SER | Serina Therapeutics, Inc. | 13.65M | -4.48% | 7,069,952 | 116.00K |
| 498 | GTBP | GT Biopharma, Inc. | 13.54M | -1.22% | 207,319 | - |
| 499 | GNTA | Genenta Science S.p.A. | 13.21M | -14.18% | 132,004 | - |
| 500 | IOBT | IO Biotech, Inc. | 13.20M | 4.80% | 1,529,614 | - |
| 501 | BCDA | BioCardia, Inc. | 13.05M | -3.91% | 42,304 | 3.00K |
| 502 | CALC | CalciMedica, Inc. | 12.95M | -1.33% | 416,106 | - |
| 503 | JUNS | Jupiter Neurosciences, Inc. | 12.74M | -6.09% | 221,640 | - |
| 504 | QNRX | Quoin Pharmaceuticals, Ltd. | 12.67M | -3.69% | 16,744 | - |
| 505 | KAPA | Kairos Pharma, Ltd. | 12.66M | 4.83% | 152,131 | - |
| 506 | SNGX | Soligenix, Inc. | 12.31M | -3.17% | 190,587 | 2.34K |
| 507 | GDTC | CytoMed Therapeutics Limited | 12.12M | 0.97% | 11,662 | 573.19K |
| 508 | NCEL | NewcelX Ltd. | 11.94M | -2.60% | 6,674 | - |
| 509 | PPBT | Purple Biotech Ltd | 11.55M | -4.51% | 7,870 | - |
| 510 | BLRX | BioLineRx Ltd. | 11.17M | -3.32% | 9,696 | 12.74M |
| 511 | OSRH | OSR Holdings, Inc. | 11.12M | -3.95% | 166,442 | -90.52K |
| 512 | MBRX | Moleculin Biotech, Inc. | 11.10M | -3.70% | 88,041 | - |
| 513 | BIVI | BioVie Inc. | 10.64M | 0.71% | 76,004 | - |
| 514 | CRIS | Curis, Inc. | 10.54M | -8.58% | 138,669 | 11.65M |
| 515 | LNAI | Lunai Bioworks Inc. | 9.72M | -27.82% | 13,438,420 | - |
| 516 | BCAB | BioAtla, Inc. | 9.41M | -8.83% | 1,540,969 | 11.00M |
| 517 | ITRM | Iterum Therapeutics plc | 9.25M | 2.16% | 669,957 | 390.00K |
| 518 | QNTM | Quantum BioPharma Ltd. | 9.09M | 0.21% | 72,389 | - |
| 519 | IMNN | Imunon, Inc. | 8.93M | -3.00% | 32,421 | - |
| 520 | RNAZ | TransCode Therapeutics, Inc. | 8.76M | -1.34% | 5,910 | - |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 8.74M | 2.48% | 27,736 | 7.70M |
| 522 | ERNA | Ernexa Therapeutics Inc. | 8.57M | 1.55% | 543,119 | 1,000.00 |
| 523 | ICU | SeaStar Medical Holding Corporation | 8.47M | -5.24% | 58,926 | 881.00K |
| 524 | PCSA | Processa Pharmaceuticals, Inc. | 8.41M | - | 23,066 | - |
| 525 | APRE | Aprea Therapeutics, Inc. | 8.37M | -6.53% | 33,469 | 285.76K |
| 526 | TOVX | Theriva Biologics, Inc. | 8.31M | -2.64% | 1,652,939 | - |
| 527 | PHGE | BiomX Inc. | 8.03M | -3.63% | 52,966 | - |
| 528 | CLGN | CollPlant Biotechnologies Ltd. | 7.79M | 1.67% | 40,953 | 2.48M |
| 529 | KPRX | Kiora Pharmaceuticals, Inc. | 7.61M | -1.43% | 22,381 | 20.00K |
| 530 | SPRC | SciSparc Ltd. | 7.59M | 1.30% | 7,457 | 1.31M |
| 531 | PULM | Pulmatrix, Inc. | 7.56M | -1.90% | 3,786 | 3.00K |
| 532 | PMCB | PharmaCyte Biotech, Inc. | 7.51M | 1.45% | 386,202 | - |
| 533 | EVGN | Evogene Ltd. | 7.39M | -2.77% | 90,821 | 3.85M |
| 534 | ALZN | Alzamend Neuro, Inc. | 7.31M | 3.23% | 75,941 | - |
| 535 | TCRT | Alaunos Therapeutics, Inc. | 7.30M | 4.81% | 11,623 | 6.00K |
| 536 | ADXN | Addex Therapeutics Ltd | 7.20M | -14.24% | 7,615 | 198.82K |
| 537 | GRDX | GridAI Technologies Corp. | 7.19M | -1.83% | 80,708 | - |
| 538 | XBIO | Xenetic Biosciences, Inc. | 7.15M | - | 22,350 | 2.98M |
| 539 | MLEC | Moolec Science SA | 6.89M | -5.19% | 9,306 | 7.83M |
| 540 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.87M | 3.11% | 336,949 | 14.83K |
| 541 | DWTX | Dogwood Therapeutics, Inc. | 6.81M | -7.76% | 96,440 | - |
| 542 | MBIO | Mustang Bio, Inc. | 6.27M | -3.42% | 30,364 | - |
| 543 | PBM | Psyence Biomedical Ltd. | 5.83M | -1.93% | 9,695 | - |
| 544 | AKTX | Akari Therapeutics, Plc | 5.81M | -24.72% | 963,407 | - |
| 545 | IMRN | Immuron Limited | 5.81M | -5.21% | 13,542 | 4.99M |
| 546 | LIMN | Liminatus Pharma, Inc. | 5.74M | -7.74% | 2,012,081 | - |
| 547 | CYCN | Cyclerion Therapeutics, Inc. | 5.73M | -1.35% | 36,689 | 2.86M |
| 548 | QNCX | Quince Therapeutics, Inc. | 5.40M | -2.02% | 14,563,177 | - |
| 549 | XTLB | XTL Biopharmaceuticals Ltd. | 5.24M | -2.22% | 10,615 | 968.00K |
| 550 | SLXN | Silexion Therapeutics Corp | 5.10M | -1.92% | 4,463 | - |
| 551 | APM | Aptorum Group Limited | 4.97M | -0.41% | 11,477 | - |
| 552 | CELZ | Creative Medical Technology Holdings, Inc. | 4.85M | - | 16,918 | 6.00K |
| 553 | BDRX | Biodexa Pharmaceuticals Plc | 4.77M | -2.22% | 61,208 | 104.90K |
| 554 | VIVS | VivoSim Labs, Inc. | 4.69M | - | 20,652 | 142.00K |
| 555 | GNPX | Genprex, Inc. | 4.66M | -0.50% | 783,498 | - |
| 556 | REVB | Revelation Biosciences, Inc. | 4.54M | 0.83% | 49,900 | - |
| 557 | BGMS | Bio Green Med Solution, Inc. | 4.46M | -1.57% | 8,419 | 81.00K |
| 558 | APVO | Aptevo Therapeutics Inc. | 4.37M | 0.86% | 27,164 | - |
| 559 | SILO | Silo Pharma, Inc. | 4.26M | -1.54% | 177,615 | 72.10K |
| 560 | INDP | Indaptus Therapeutics, Inc. | 4.19M | -4.59% | 20,197 | - |
| 561 | GRI | GRI Bio, Inc. | 3.83M | 2.71% | 51,926 | - |
| 562 | MTNB | Matinas BioPharma Holdings, Inc. | 3.81M | -6.68% | 6,527 | - |
| 563 | ASBP | Aspire Biopharma Holdings, Inc. | 3.51M | -20.13% | 360,295 | 1.94K |
| 564 | OGEN | Oragenics, Inc. | 3.42M | 1.56% | 117,735 | - |
| 565 | GLMD | Galmed Pharmaceuticals Ltd. | 3.35M | -0.05% | 13,850 | - |
| 566 | NCNA | NuCana plc | 3.32M | -6.45% | 71,770 | - |
| 567 | XRTX | XORTX Therapeutics Inc. | 3.25M | 6.45% | 18,094 | - |
| 568 | HCWB | HCW Biologics Inc. | 3.03M | 5.54% | 10,107,160 | 422.03K |
| 569 | ENVB | Enveric Biosciences, Inc. | 2.79M | 0.50% | 19,737 | - |
| 570 | ADIL | Adial Pharmaceuticals, Inc. | 2.43M | -10.05% | 60,141 | - |
| 571 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.24M | -5.78% | 349,635 | 1.36M |
| 572 | SCNI | Scinai Immunotherapeutics Ltd. | 2.24M | 0.71% | 16,443 | 1.15M |
| 573 | ENSC | Ensysce Biosciences, Inc. | 2.24M | 32.91% | 7,782,668 | 4.49M |
| 574 | AZTR | Azitra, Inc. | 2.21M | -13.64% | 1,892,090 | 7.50K |
| 575 | BBLG | Bone Biologics Corporation | 2.17M | -2.42% | 10,996 | - |
| 576 | CLDI | Calidi Biotherapeutics, Inc. | 2.15M | -4.31% | 169,913 | - |
| 577 | KALA | KALA BIO, Inc. | 2.07M | 0.16% | 3,227,931 | - |
| 578 | BRTX | BioRestorative Therapies, Inc. | 2.03M | -9.24% | 1,818,447 | 383.40K |
| 579 | ONCO | Onconetix, Inc. | 1.86M | -0.97% | 70,360 | 815.37K |
| 580 | PPCB | Propanc Biopharma, Inc. | 1.76M | -2.18% | 926,854 | - |
| 581 | JAGX | Jaguar Health, Inc. | 1.65M | -8.04% | 690,027 | 11.79M |
| 582 | DRMA | Dermata Therapeutics, Inc. | 1.40M | -2.46% | 43,474 | - |
| 583 | CNSP | CNS Pharmaceuticals, Inc. | 1.36M | -2.65% | 29,670 | - |
| 584 | CMND | Clearmind Medicine Inc. | 1.01M | -9.80% | 544,114 | - |
| 585 | OKYO | OKYO Pharma Limited | 932.66K | 1.25% | 161,940 | - |
| 586 | CDT | CDT Equity Inc. | 827.74K | 3.78% | 40,542 | - |
| 587 | VRAX | Virax Biolabs Group Limited | 815.85K | -7.30% | 79,043 | 2.99K |
| 588 | ADTX | Aditxt, Inc. | 788.82K | -4.73% | 87,272 | 5.95K |
| 589 | ELAB | PMGC Holdings Inc. | 361.83K | -2.93% | 24,254 | 285.95K |
| 590 | MTVA | MetaVia Inc. | 309.45K | -2.63% | 835,703 | - |
| 591 | CANF | Can-Fite BioPharma Ltd. | 19.57K | 0.29% | 51,686 | 560.00K |